AtriCure, Inc. ATRC

About AtriCure, Inc. (ATRC): stock profile, AI score and financials

AtriCure, Inc. (ATRC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ATRC at 58.9/100 on a composite quality score built from its SEC filings, placing it at rank #972 of 2,925 stocks — the top half of the AI-ranked universe. ATRC scores in the top quartile across earnings quality (97.6). Areas of concern include revenue scale (38.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 17.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AtriCure, Inc. reports quarterly revenue of $153.6M, net income of $9.0M, an operating margin of 6.3%. Top institutional holders of ATRC by reported 13-F value include BlackRock, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. ATRC trades on the Nasdaq exchange and files with the SEC under CIK 1323885. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ATRC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AtriCure, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1323885 →